INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
KS

Kornfeld Steven

DirectorCIK 0001814653

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Tender of shares
U—
3,960 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Forte Biosciences, Inc.Director · Aug 27, 2026
9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D
—
1,200 sh
Aug 27, 2026
Aug 27, 2026
traded Aug 27, 2026
+0d
SEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
800 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
2,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
31.0K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
18.4K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC FORM 4

Evidence